Alternatives
Alternatives to Mydayis 3.125 mg/3.125 mg/3.125 mg/3.125 mg extended-release capsule
There are 2 alternatives to this medicine in the catalogue: the same active ingredient (Amphetamine and Dextroamphetamine), strength (3.125 mg/3.125 mg/3.125 mg/3.125 mg) and dosage form (extended-release capsule) from 2 other makers or registers. The table compares packs, storage, lead time, documents and availability.
Side by side
The first row is the medicine you came from.
| Medicine | Manufacturer | Register | Packs | Storage | Lead time | Documents | Availability |
|---|---|---|---|---|---|---|---|
| Mydayis 3.125 mg/3.125 mg/3.125 mg/3.125 mg extended-release capsuleThis pageOral | Takeda Pharmaceuticals | US FDA | 100 capsules | Store at room temperature, 20ºC to 25ºC (68ºF to 77ºF). Excursions permitted between 15ºC to 30ºC (59ºF to 86ºF). | On request | — | Available on request |
| Amphetamine and Dextroamphetamine 3.125 mg/3.125 mg/3.125 mg/3.125 mg extended-release capsuleOral | — | US FDA | 100 capsules, 100 capsules | Store at room temperature, 20ºC to 25ºC (68ºF to 77ºF). Excursions permitted between 15ºC to 30ºC (59ºF to 86ºF). | On request | — | Available on request |
| Mixed Salts of a Single-Entity Amphetamine Product 3.125 mg/3.125 mg/3.125 mg/3.125 mg extended-release capsuleOral | SpecGx | US FDA | 100 capsules | Store at room temperature, 20°C to 25°C (68°F to 77°F). Excursions permitted between 15°C to 30°C (59°F to 86°F). | On request | — | Available on request |
Alternatives are listed for sourcing. Whether one medicine can replace another is the prescriber's decision, under the rules of the destination country.
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Back to Mydayis 3.125 mg/3.125 mg/3.125 mg/3.125 mg extended-release capsuleNot sure which maker to choose?
Request a quote for the medicine and we will propose the options that fit your country's import rules and timelines.